Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SysVac01-C60P2 MenB OMV vaccine mucosal immunity study
2008-001927-74Phase 2Completed
- Sponsor
- University Hospitals Bristol and Weston NHS Foundation Trust
- Start
- Nov 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of NZ MenB OMV vaccine in meningococcal disease (2 arms), sponsored by University Hospitals Bristol and Weston NHS Foundation Trust. Primary endpoints: T cell phenotype and function, Mucosal B cell antibody production and 1 more. Started Nov 2010; status: completed.
02
Drugs
NZ MenB OMV vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on 2008-001927-74.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001927-74.